CO4761062A1 - Procedimientos para inhibir tumores de colon - Google Patents

Procedimientos para inhibir tumores de colon

Info

Publication number
CO4761062A1
CO4761062A1 CO97003856A CO97003856A CO4761062A1 CO 4761062 A1 CO4761062 A1 CO 4761062A1 CO 97003856 A CO97003856 A CO 97003856A CO 97003856 A CO97003856 A CO 97003856A CO 4761062 A1 CO4761062 A1 CO 4761062A1
Authority
CO
Colombia
Prior art keywords
columan
tumors
inhibit
procedures
hexamethyleneimino
Prior art date
Application number
CO97003856A
Other languages
English (en)
Inventor
Maria Luisa Brandy
Francesco Tonelli
Original Assignee
Eli Lilly And Cvompany
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly And Cvompany filed Critical Eli Lilly And Cvompany
Publication of CO4761062A1 publication Critical patent/CO4761062A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Un medicamento que contiene un compuesto que tiene la fórmula en la que R1 y R3 son independientemente hidrógeno,en el que Ar es feniloopcionalmente sustituido;R2 se selecciona entre el grupo compuesto por pirrolidino, hexametilenimino y piperidino; o una de sus sales o solvatos farmacéuticamente aceptables; en la preparación de un medicamento útil para inhibir cáncer de colon en un mamífero.
CO97003856A 1996-01-29 1997-01-28 Procedimientos para inhibir tumores de colon CO4761062A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
CO4761062A1 true CO4761062A1 (es) 1999-04-27

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97003856A CO4761062A1 (es) 1996-01-29 1997-01-28 Procedimientos para inhibir tumores de colon

Country Status (19)

Country Link
EP (1) EP0921799A4 (es)
JP (1) JP2000503994A (es)
KR (1) KR19990082054A (es)
CN (1) CN1209745A (es)
AR (1) AR010978A1 (es)
AU (1) AU707892B2 (es)
BR (1) BR9700778A (es)
CO (1) CO4761062A1 (es)
CZ (1) CZ235498A3 (es)
EA (1) EA001104B1 (es)
ID (1) ID15917A (es)
IL (1) IL125521A (es)
MX (1) MX9806036A (es)
NO (1) NO983451L (es)
NZ (1) NZ331105A (es)
PL (1) PL328147A1 (es)
TW (1) TW446560B (es)
WO (1) WO1997026877A1 (es)
YU (1) YU2397A (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
EP0652004B1 (en) * 1993-10-15 2002-07-10 Eli Lilly And Company Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
AU2123997A (en) 1997-08-20
KR19990082054A (ko) 1999-11-15
EP0921799A1 (en) 1999-06-16
MX9806036A (es) 1998-11-29
WO1997026877A1 (en) 1997-07-31
IL125521A0 (en) 1999-03-12
NO983451D0 (no) 1998-07-27
ID15917A (id) 1997-08-21
YU2397A (en) 1999-11-22
BR9700778A (pt) 1998-10-06
AR010978A1 (es) 2000-08-02
PL328147A1 (en) 1999-01-18
NZ331105A (en) 2000-06-23
CN1209745A (zh) 1999-03-03
CZ235498A3 (cs) 1999-02-17
TW446560B (en) 2001-07-21
EP0921799A4 (en) 2002-03-13
NO983451L (no) 1998-07-27
AU707892B2 (en) 1999-07-22
JP2000503994A (ja) 2000-04-04
EA001104B1 (ru) 2000-10-30
IL125521A (en) 2001-11-25
EA199800677A1 (ru) 1999-02-25

Similar Documents

Publication Publication Date Title
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
RU94045846A (ru) Применение производных бензотиофена для ингибирования тромбина
PA8480101A1 (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
EA200100766A1 (ru) Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
ES2195355T3 (es) Formulado farmaceutico que contiene voriconazol.
ES2266459T3 (es) Uso de compuestos de azetidinona sustituidos para el tratamiento de sitosterolemia.
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
CO5031247A1 (es) Compuestos triciclicos sustituidos
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES8706139A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
RU94045156A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования преждевременного полового созревания
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
CO4650039A1 (es) Benzotiofenos amorfos, procedimientos de preparacion y procedimientos de uso
CO4750819A1 (es) Procedimientos para inhibir el inhibidor del activador del plasminogeno 1
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
CO4761062A1 (es) Procedimientos para inhibir tumores de colon
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
AR027035A1 (es) Pirroles sustituidos
ECSP972009A (es) Procedimientos para inhibir tumores de colon